ADJUVANT SYSTEMIC THERAPY IN WOMEN WITH EARLY-STAGE BREAST-CANCER AT HIGH-RISK FOR RELAPSE

被引：24

作者：

DAVIDSON, NE

ABELOFF, MD

机构：

[1] Johns Hopkins Oncology Center, Baltimore, MD

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1992年 / 84卷 / 05期

关键词：

D O I：

10.1093/jnci/84.5.301

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：301 / 305

页数：5

共 35 条

[1]

ABELOFF MD, 1990, J NATL CANCER I, V82, P1220, DOI 10.1093/jnci/82.14.1220-a

[2] 16-WEEK DOSE-INTENSE CHEMOTHERAPY IN THE ADJUVANT TREATMENT OF BREAST-CANCER [J].

ABELOFF, MD ;

BEVERIDGE, RA ;

DONEHOWER, RC ;

FETTING, JH ;

DAVIDSON, NE ;

GORDON, GG ;

WATERFIELD, WC ;

DAMRON, DJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (07) :570-574

[3]

ANTMAN K, 1991, NEW STRATEGIES BONE, P423

[4]

ARMITAGE JO, 1989, BLOOD, V73, P1749

[5]

BEVILACQUA G, 1989, CANCER RES, V49, P5185

[6]

BONADONNA G, 1987, ADJUVANT THERAPY CAN, V5, P211

[7] 16-WEEK, DOSE-INTENSE CHEMOTHERAPY IN ADJUVANT TREATMENT OF BREAST-CANCER [J].

BUZDAR, AU ;

HORTOBAGYI, GN .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (14) :1220-1220

[8]

BUZDAR AU, 1990, ADJUVANT THERAPY CAN, V6, P210

[9] ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN PLUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN THE TREATMENT OF RESECTABLE BREAST-CANCER WITH MORE THAN 3 POSITIVE AXILLARY NODES [J].

BUZZONI, R ;

BONADONNA, G ;

VALAGUSSA, P ;

ZAMBETTI, M .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (12) :2134-2140

[10] MUTATIONS IN HUMAN-BREAST CANCER - AN OVERVIEW [J].

CALLAHAN, R ;

CAMPBELL, G .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (23) :1780-1786

← 1 2 3 4 →